Trials / Unknown
UnknownNCT02323841
Feasibility Study: Conservative Treatment in Cervical Cancer
Feasibility Study: Conservative Treatment in Cervical Cancer FIGO Stage IB1-IIA1 > 2cm
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Catholic University of the Sacred Heart · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
Currently conservative treatment for patients of childbearing affected by cervical cancer is reserved for women with FIGO stage IA2 - IB1 with tumor size less than 2 cm . The trachelectomy and the cone biopsy with pelvic lymphadenectomy are the choice for these patients wishing to preserve their reproductive function. In this context , recently literature show the results about the use of neo-adjuvant chemotherapy about the reduction of tumor volume and therefore the magnitude of the subsequent surgical treatment (including patients with tumors larger than 2 cm ). So it becomes crucial a prospective analysis on the possibility to include in this type of treatment patients with stage IB1 and IIA1 with tumor size greater than 2 cm ( up to 4 cm ) . The current study , in fact , would like to do a prospective evaluation on the advantages of neo-adjuvant chemotherapy in the possibility of broadening the inclusion criteria to conservative treatment in women , suffering from cervical cancer, stage IB1 and IIA1 ( with tumor volume between 2 and 4 cm) and wishing to preserve their reproductive function.
Detailed description
The investigators would like to be conservative in young patients affected by early stage cervical cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | conservative treatment | we performed pelvic lymphadenectomy before neoadjuvant chemotherapy and conization as conservative treatments |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2014-03-01
- Completion
- 2015-03-01
- First posted
- 2014-12-24
- Last updated
- 2014-12-24
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT02323841. Inclusion in this directory is not an endorsement.